Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael A. Brasch is active.

Publication


Featured researches published by Michael A. Brasch.


Methods in Enzymology | 2000

GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes.

Albertha J. M. Walhout; Gary F. Temple; Michael A. Brasch; James L. Hartley; Monique A. Lorson; Sander van den Heuvel; Marc Vidal

Publisher Summary Complete genome sequences are available for three model organisms— Escherichia coli , Saccharomyces cerevisiae , and Caenorhabditis elegans —and for several pathogenic microorganisms such as Helicobacter pylori . Complete genome sequences are expected to become available soon for other model organisms and for humans. This information is expected to revolutionize the way biological questions can be addressed. Molecular mechanisms should now be approachable on a more global scale in the context of (nearly) complete sets of genes, rather than by analyzing genes individually. However, most open reading frames (ORFs) predicted from sequencing projects have remained completely uncharacterized at the functional level. The emerging field of functional genomics addresses this limitation by developing methods to characterize the function of large numbers of predicted ORFs simultaneously.


Nature Genetics | 2001

Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegans

Jérôme Reboul; Philippe Vaglio; Nia Tzellas; Nicolas Thierry-Mieg; Troy Moore; Cindy Jackson; Tadasu Shin-I; Yuji Kohara; Danielle Thierry-Mieg; Jean Thierry-Mieg; Hongmei Lee; Joseph Hitti; Lynn Doucette-Stamm; James L. Hartley; Gary F. Temple; Michael A. Brasch; Jean Vandenhaute; Philippe Lamesch; David E. Hill; Marc Vidal

The genome sequences of Caenorhabditis elegans, Drosophila melanogaster and Arabidopsis thaliana have been predicted to contain 19,000, 13,600 and 25,500 genes, respectively. Before this information can be fully used for evolutionary and functional studies, several issues need to be addressed. First, the gene number estimates obtained in silico and not yet supported by any experimental data need to be verified. For example, it seems biologically paradoxical that C. elegans would have 50% more genes than Drosophilia. Second, intron/exon predictions need to be tested experimentally. Third, complete sets of open reading frames (ORFs), or “ORFeomes,” need to be cloned into various expression vectors. To address these issues simultaneously, we have designed and applied to C. elegans the following strategy. Predicted ORFs are amplified by PCR from a highly representative cDNA library using ORF-specific primers, cloned by Gateway recombination cloning and then sequenced to generate ORF sequence tags (OSTs) as a way to verify identity and splicing. In a sample (n=1,222) of the nearly 10,000 genes predicted ab initio (that is, for which no expressed sequence tag (EST) is available so far), at least 70% were verified by OSTs. We also observed that 27% of these experimentally confirmed genes have a structure different from that predicted by GeneFinder. We now have experimental evidence that supports the existence of at least 17,300 genes in C. elegans. Hence we suggest that gene counts based primarily on ESTs may underestimate the number of genes in human and in other organisms.


Nature Genetics | 2001

The gene number dilemma: Direct evidence for at least 19,000 protein-encoding genes in C. elegans and implications for the human genome

Jérôme Reboul; Philippe Vaglio; N. Tzellas; C. Jackson; Troy Moore; Yuji Kohara; Jean Thierry-Mieg; Danielle Thierry-Mieg; Joseph Hitti; Lynn Doucette-Stamm; James L. Hartley; Gary F. Temple; Michael A. Brasch; David E. Hill; Marc Vidal

The gene number dilemma: direct evidence for at least 19,000 protein-encoding genes in Caenorhabditis elegans and implications for the human genome


Genome Research | 2000

DNA Cloning Using In Vitro Site-Specific Recombination

James L. Hartley; Gary F. Temple; Michael A. Brasch


Science | 2000

Protein Interaction Mapping in C. elegans Using Proteins Involved in Vulval Development

Albertha J. M. Walhout; Raffaella Sordella; Xiaowei Lu; James L. Hartley; Gary F. Temple; Michael A. Brasch; Nicolas Thierry-Mieg; Marc Vidal


Nature Genetics | 2003

C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome- scale protein expression

Jérôme Reboul; Philippe Vaglio; Jean François Rual; Philippe Lamesch; Monica Martinez; Christopher M. Armstrong; Siming Li; Laurent Jacotot; Nicolas Bertin; Rekin's Janky; Troy Moore; James R. Hudson; James L. Hartley; Michael A. Brasch; Jean Vandenhaute; Simon J. Boulton; Gregory A. Endress; Sarah Jenna; Eric Chevet; Vasilis Papasotiropoulos; Peter P. Tolias; Jason Ptacek; Michael Snyder; Raymond Huang; Mark R. Chance; Hongmei Lee; Lynn Doucette-Stamm; David E. Hill; Marc Vidal


Genome Research | 2004

Concerted Assembly and Cloning of Multiple DNA Segments Using In Vitro Site-Specific Recombination: Functional Analysis of Multi-Segment Expression Clones

David Cheo; Steven A. Titus; Devon R N Byrd; James Hartley; Gary F. Temple; Michael A. Brasch


Archive | 2001

METHODS AND COMPOSITIONS FOR SYNTHESIS OF NUCLEIC ACID MOLECULES USING MULTIPLE RECOGNITION SITES

Jonathan D. Chesnut; John Carrino; Louis Leong; Knut R. Madden; Martin A. Gleeson; James Fan; Michael A. Brasch; David Cheo; James L. Hartley; Devon R. N. Byrd; Gary F. Temple


Genome Research | 2004

ORFeome Cloning and Systems Biology: Standardized Mass Production of the Parts From the Parts-List

Michael A. Brasch; James L. Hartley; Marc Vidal


Archive | 1999

Recombination cloning using engineered recombination sites

James L. Hartley; Michael A. Brasch

Collaboration


Dive into the Michael A. Brasch's collaboration.

Top Co-Authors

Avatar

James L. Hartley

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Cheo

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge